RxDoctor Payments Data

Jeremy Prine, MD

Interventional Pain Medicine · Macon, GANPI 1508000332

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 103 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Boston Scientific at 44.1% of the total. 2025 is the largest year on record at $2,152, 7.3 times the $295 reported in 2019.

$6,720in general payments, 2019–2025

Across 103 payments — averaging $65.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$3K
  • Abbott$1K
  • Nevro Corp.$1K
  • Foundation Fusion Solutions, LLC$437
  • SPR Therapeutics, Inc$174
  • Si-bone, Inc.$148
  • plus $399 from 5 others

What the payments were for

  • Food & beverage$6,720100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,720 in reported general payments places this provider in the 60th percentile of 129 interventional pain medicine providers in Georgia.

See all interventional pain medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$575,851
Medicare patients
556
Services billed
7,058

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen1,924$48,342
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen531$14,933
MovantikNaloxegol Oxalate35$14,003
Pregabalin475$12,276
Lidocaine85$8,885
Gabapentin472$6,642
Diclofenac Sodium107$5,583
Lidocaine-PrilocaineLidocaine/Prilocaine69$3,421
Tizanidine Hcl317$3,397
Buprenorphine13$3,154
Cyclobenzaprine Hcl312$2,727
Oxycodone Hcl149$2,441
Methocarbamol113$1,646
Celecoxib84$1,610
Tramadol Hcl ErTramadol Hcl30$1,593

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Macon

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →